The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia

For medical treatment to reduce cholesterol levels by most international cardiology and nephrology associations recommended prescriptions of statin as monotherapy or combination with other drugs. The tоpic of this article is devoted to the comparative characteristic of this group of drugs for use in...

Full description

Bibliographic Details
Main Authors: D.D. Ivanov, Ya.A. Dombrovskyi
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2015-04-01
Series:Počki
Subjects:
Online Access:http://kidneys.zaslavsky.com.ua/article/view/75374
_version_ 1819281521005035520
author D.D. Ivanov
Ya.A. Dombrovskyi
author_facet D.D. Ivanov
Ya.A. Dombrovskyi
author_sort D.D. Ivanov
collection DOAJ
description For medical treatment to reduce cholesterol levels by most international cardiology and nephrology associations recommended prescriptions of statin as monotherapy or combination with other drugs. The tоpic of this article is devoted to the comparative characteristic of this group of drugs for use in patients with chronic kidney disease associated with dyslipidemia. The main part of the article is an analysis of pharmacodynamics, efficacy, safety and expediency of using rosuvastatin, a drug from the group of the last generation of statins.
first_indexed 2024-12-24T01:01:00Z
format Article
id doaj.art-6a07a5d7237e4ccd95b1de56212a5616
institution Directory Open Access Journal
issn 2307-1257
2307-1265
language English
last_indexed 2024-12-24T01:01:00Z
publishDate 2015-04-01
publisher Zaslavsky O.Yu.
record_format Article
series Počki
spelling doaj.art-6a07a5d7237e4ccd95b1de56212a56162022-12-21T17:23:22ZengZaslavsky O.Yu.Počki2307-12572307-12652015-04-0152.12475110.22141/2307-1257.0.2.12.2015.7537475374The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemiaD.D. Ivanov0Ya.A. Dombrovskyi1National Medical Academy of Postgraduate Education named after P. L. Shupyk City clinical hospital №18, KyivNational Medical Academy of Postgraduate Education named after P. L. Shupyk City clinical hospital №18, KyivFor medical treatment to reduce cholesterol levels by most international cardiology and nephrology associations recommended prescriptions of statin as monotherapy or combination with other drugs. The tоpic of this article is devoted to the comparative characteristic of this group of drugs for use in patients with chronic kidney disease associated with dyslipidemia. The main part of the article is an analysis of pharmacodynamics, efficacy, safety and expediency of using rosuvastatin, a drug from the group of the last generation of statins.http://kidneys.zaslavsky.com.ua/article/view/75374chronic kidney diseasedyslipidemiastatinsrosuvastatin
spellingShingle D.D. Ivanov
Ya.A. Dombrovskyi
The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
Počki
chronic kidney disease
dyslipidemia
statins
rosuvastatin
title The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
title_full The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
title_fullStr The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
title_full_unstemmed The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
title_short The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
title_sort use of statin drugs in patients with chronic kidney disease combined with dyslipidemia
topic chronic kidney disease
dyslipidemia
statins
rosuvastatin
url http://kidneys.zaslavsky.com.ua/article/view/75374
work_keys_str_mv AT ddivanov theuseofstatindrugsinpatientswithchronickidneydiseasecombinedwithdyslipidemia
AT yaadombrovskyi theuseofstatindrugsinpatientswithchronickidneydiseasecombinedwithdyslipidemia
AT ddivanov useofstatindrugsinpatientswithchronickidneydiseasecombinedwithdyslipidemia
AT yaadombrovskyi useofstatindrugsinpatientswithchronickidneydiseasecombinedwithdyslipidemia